| 000 | 01292 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250514225321.0 | ||
| 264 | 0 | _c20050603 | |
| 008 | 200506s 0 0 eng d | ||
| 022 | _a0022-5347 | ||
| 024 | 7 |
_a10.1016/s0022-5347(05)60291-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHoeltl, Wolfgang | |
| 245 | 0 | 0 |
_aRe: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? _h[electronic resource] |
| 260 |
_bThe Journal of urology _cJun 2005 |
||
| 300 |
_a2205; author reply 2205-6 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 | _aCause of Death |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMass Screening _xtrends |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
| 650 | 0 | 4 |
_aProstatectomy _xtrends |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xblood |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aMüller, Matthias M | |
| 700 | 1 | _aLunglmayr, Gerhard | |
| 773 | 0 |
_tThe Journal of urology _gvol. 173 _gno. 6 _gp. 2205; author reply 2205-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0022-5347(05)60291-1 _zAvailable from publisher's website |
| 999 |
_c15543163 _d15543163 |
||